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Background
The gastric cancer (GC) is the most common gastrointes-
tinal tumor and it is the second cause of death in Mexico.
Recently new agents chemotherapeutic, combinations
and multimodal treatments have been developed. Tradi-
tionally your outcomes assessment is for clinical answers,
tumor size, toxicity, survival free of disease or global sur-
vival. However, recently attention has been called to the
assessment of quality of life, which OMS defines as the
state of complete well-being, not only physique but also
emotional and social. The quality of life implies the global
evaluation that a person makes of his life with basis in his
personal (demographic, value, personality, emotions,
interpersonal relationships) characteristics and in external
factors, provoked for illnesses and the treatment, includes
the spheres physical, psychological and social health seen
as different areas that are influenced by experiences,
beliefs, expectations and people's perceptions. Each one
can be measured in two dimensions: an objective evalua-
tion and the individual's subjective perception. This last
one can explain that two people with similar state of
health can have very different quality of life. The assess-
ment of the Quality of life has had a wide development,
through generic questionnaires designed for patient with
cancer, the EORTC has developed a modulate for patient
with gastric cancer that evaluates the quality of life with
related to the disfagia, feeding restrictions, reflux, and
abdominal pain, as well as specific symptoms of the
chemotherapy or radiotherapy the questionnaire QLQ
STO-22. The objective of this study was to adapt and vali-
date of the instrument EORTC QLQ-STO22 in a Mexican
population from Instituto Nacional de Cancerologia
(INCan)
Materials and methods
Sample
Ten patients with Gastric Cancer, the mean age is 54.5
years old (35 to 73 years). Seven were female and three
men. Their occupations were: one merchant and six are
devoted at the home. All three male patients were car driv-
ers. All patients were Mexican, and Mexican-born and
their maternal language was Mexican Spanish, and all can
read and write Mexican Spanish. Five patients were mar-
ried, one was separate, one was bachelor, one was free
union and two were widows.
Procedure
The process of adaptation follow the norms pointed out
by the European Organization for the Study and Treat-
ment of Cancer (EORTC), which has been contacted with
this organization and it is had their supervision and
authorization.
1. Process of translate – retranslate from original English
version.
2. Content validity by a group of the experts in Gastroen-
terology and psychooncology.
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3. Test pilot in a described sample. Each patient answered
the questionnaire EORTC QLQ STO-22 and immediately
they were interviewed to search questions difficult, confu-
sion, offensive, words difficult to understand.
4. Convenient adjustments to the Instrument taking into
account the frequency of difficulties, and patients' sugges-
tions.
Results
Pilot Testing
The items 32, 33, 34, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46,
47, 48, 50, 51 and 52, were not associated with any diffi-
cult to answer, confusing, difficult to understand, upset-
ting, neither offensive, nor any patient asked the question
in a different way.
Question 31 Five patients did not understand what the
word "sólidos" (solids) means or the expression "alimen-
tos sólidos" (solid food), two patients proposed examples
of solid food as "¿Ha tenido problemas con al comer
carne, pan, tortilla?" (Had you have trouble to eat meat,
bread, tortilla?).
The research team suggests changing the expression "ali-
mentos duros" (hard food) for the alternative expression
"alimentos sólidos" (solid food). Therefore, the definite
form of the question is: Have you had problems eating
hard food?. This is the only question that requires modifi-
cation.
Question 35 and question 36 According to the patients
these questions ask the same thing. However, the research
team concluded that the difference between both ques-
tions is subtle but important to differentiate. Therefore,
these questions must remain unchanged. Question 49
The question 49 provoked a reaction of embarrassment in
some patients; however, the research team decided this
should remain unchanged.
Conclusion
In Mexico, there is a lack of instruments to measure qual-
ity of life in GC, standardized and adapted to the Mexican
culture that allow an appropriate assessment of the qual-
ity of life, and serve as additional tools of the clinical: the
patient's integral evaluation with GC and the conduction
of clinical trials. For this reason, it is required of transla-
tion, adaptation and validation of instruments of com-
mon use in the rest of the world, with the purpose of
evaluating the impact of the oncological treatments for
the GC from the patient's perspective in the physical, psy-
chological, and social area. At the same time to help in the
physician and patient's decision about the treatments and
their administration, to identify the patient's needs, and
the way that support services can collaborate during the
treatment process.